Dr. Ashvin Rangole Surgical Oncologist in Indore

Dr. Ashvin Rangole
Surgical Oncologist, Indore


  • Dr. Ashvin Rangole is a  consultant surgical oncologist at CHL-CBCC cancer center, Indore
  • 8+yrs of experience after formal oncotraining


  • Surgical Oncology (Cancer Surgery)

  • Oncology


  • Transthoracic esophagectomy with three-field lymphadenectomy
  • Minimal access lung cancer surgery with mini-thoracotomy approach with systematic mediastinal lymphadenectomy
  • Gynaec malignancies
  • Organ preservation approach: Head & Neck cancer, Breast cancer, Rectal cancer
  • Peritonectomy procedures for abdominal cancers spreading to peritoneum like stomach, intestinal, ovary, appendiceal cancers etc.
  • The only surgeon in Central India performing HIPEC treatment for abdominal cancers.


  • MBBS from NSCB Medical College, Jabalpur
  • MS( General Surgery) from Gandhi Medical College & Hamidia Hospital (Government) Bhopal
  • Formal training in Surgical oncology from Tata Memorial Hospital, Mumbai(Sept 2002 to July 2006)
  • Training in Thoracic division of National Cancer Center, TOKYO, Japan : surgical    advances in Lung Cancer and Mediastinal Surgery(Feb to March 2009)
  • Surgical training Fellowship at Juntendo University Hospital, TOKYO, JAPAN. Learning Japanese techniques of  three-field lymphadenectomy during  Radical Esophagectomy  and D-2 lymphadenectomy with radical gastrectomy (March to April 2009)
  • Clinical training fellowship in "peritoneal surface malignancy program" at Washington cancer Institute.

Practice Information

CHL CBCC Cancer Center, Indore

CHL CBCC Cancer Center, Indore

142 Phadnis Colon, A.B. Road, Indore, Madhya Pradesh - 452008

Patient Experience

Your participation in the survey will help other patients make informed decisions. You will also be helping Dr. Ashvin Rangole and his staff know how they are doing and how they can improve their services.

Achievements & Contributions

  • The only surgeon in Central India performing cytoreductive peritonei tommy procedures with hyperthermic intraperitoneal chemotherapy treatment.